These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15146720)

  • 1. Statin therapy: more than meets the eye?
    McCain J
    Manag Care; 2004 Apr; 13(4):40-9. PubMed ID: 15146720
    [No Abstract]   [Full Text] [Related]  

  • 2. Study stirs debate about statin use in those without high cholesterol.
    Mayo Clin Womens Healthsource; 2009 Apr; 13(4):3. PubMed ID: 19255535
    [No Abstract]   [Full Text] [Related]  

  • 3. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimizing statin drug therapy.
    Ramsey LA; Miles AJ
    Adv Nurse Pract; 2002 Mar; 10(3):27-8. PubMed ID: 12418333
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid treatment in ethnically diverse underserved older adults with diabetes mellitus: statin use, goal attainment, and health disparities in the informatics for diabetes education and telemedicine project.
    Weinstock RS; Izquierdo R; Goland R; Palmas W; Teresi JA; Eimicke JP; Shea S;
    J Am Geriatr Soc; 2010 Feb; 58(2):401-2. PubMed ID: 20370876
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges associated with chronic medication compliance and adherence.
    Giaquinta D
    Manag Care Interface; 2002 Jan; 15(1):51-2. PubMed ID: 11865809
    [No Abstract]   [Full Text] [Related]  

  • 9. More than a statin.
    Underwood A
    Newsweek; 2004 Aug; 144(6):54. PubMed ID: 15449505
    [No Abstract]   [Full Text] [Related]  

  • 10. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ongoing clinical trials by vascular statin, cerivastatin].
    Tomita N; Morishita R; Ogihara T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():477-82. PubMed ID: 11347117
    [No Abstract]   [Full Text] [Related]  

  • 12. Identifying patients for aggressive cholesterol lowering: the risk curve concept.
    Robinson JG; Stone NJ
    Am J Cardiol; 2006 Nov; 98(10):1405-8. PubMed ID: 17134640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance and refill pattern behavior with HMG-CoA reductase inhibitors after acute myocardial infarction.
    Coombs JH; Cornish L; Hiller P; Smith DG
    Manag Care Interface; 2002 Jan; 15(1):54-8, 60. PubMed ID: 11828605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive lipid reduction provides additional clinical benefit.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():1, 4. PubMed ID: 12608148
    [No Abstract]   [Full Text] [Related]  

  • 18. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.
    Lima JA; Desai MY; Steen H; Warren WP; Gautam S; Lai S
    Circulation; 2004 Oct; 110(16):2336-41. PubMed ID: 15477398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
    Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pleiotropic effects of statins].
    Palomäki A
    Duodecim; 2004; 120(4):411-8. PubMed ID: 15065459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.